Detalles de la búsqueda
1.
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens.
Br J Haematol;
2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710589
2.
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report.
Haematologica;
2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721751
3.
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort.
Hematol Oncol;
42(1): e3249, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287529
4.
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience.
Ann Hematol;
2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38687347
5.
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.
Br J Haematol;
203(2): 224-236, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37495265
6.
Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment.
Blood;
137(16): 2182-2195, 2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33181836
7.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Blood;
137(25): 3507-3517, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651883
8.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Blood;
137(10): 1365-1376, 2021 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32992344
9.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica;
108(8): 2091-2100, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632738
10.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Hematol Oncol;
41(5): 877-883, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392141
11.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol;
98(12): 1856-1868, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772428
12.
Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosis.
J Peripher Nerv Syst;
28(2): 262-265, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36859783
13.
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
J Peripher Nerv Syst;
28(3): 522-527, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246762
14.
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study.
Br J Haematol;
199(1): 54-60, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35906881
15.
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.
Haematologica;
107(4): 868-876, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092056
16.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol;
40(1): 31-39, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34694649
17.
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study.
Br J Haematol;
193(2): 316-324, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33058237
18.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Blood;
133(11): 1205-1216, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30602617
19.
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Hematol Oncol;
39(3): 326-335, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739461
20.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol;
106(4): 493-499, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33378569